These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6038874)

  • 1. Effect of SK&F-12185 [dl-2(p-aminophenyl)-2-phenylethylamine] on adrenocortical function in primary aldosteronism.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1337-40. PubMed ID: 6038874
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of d-2(p-aminophenyl)-2-phenylethylamine (SK&F-12185) in Cushing's syndrome associated with adrenocortical carcinoma.
    Gabrilove JL; Nicolis GL; Gallagher TF
    Metabolism; 1968 Oct; 17(10):936-42. PubMed ID: 4877990
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1550-7. PubMed ID: 6075585
    [No Abstract]   [Full Text] [Related]  

  • 4. [On regulation of the daily rhythm of adrenal cortex hormones in corticosteroma].
    Gur'eva IG; Kertsman VI
    Probl Endokrinol Gormonoter; 1966; 12(4):3-7. PubMed ID: 4301286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kidney blood supply and functional state of the adrenal cortex in patients with hypertensive disease].
    Mikhaĭlin SE
    Vrach Delo; 1971 Jun; (6):4-6. PubMed ID: 5093594
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
    Davis WW; Newsome HH; Wright LD; Hammond WG; Easton J; Bartter FC
    Am J Med; 1967 Apr; 42(4):642-7. PubMed ID: 6024721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attempted experimental chronic block of adrenal cortex hormone synthesis during growth].
    Sendrail M; Gleizes L; Sendrail-Pesqué M; Chkili T; Fabre MT; Vassal D
    Pathol Biol (Paris); 1969 Nov; 17(21):939-51. PubMed ID: 4907649
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations on the adrenocortical function of normal and obese dogs.
    Rijnberk A; Kinderen PJ der
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):521. PubMed ID: 5582725
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-tumorous "primary" aldosteronism: II. Type not relieved by glucocorticoid.
    Salti IS; Ruse JL; Stiefel M; Delarue NC; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):11-6. PubMed ID: 5793350
    [No Abstract]   [Full Text] [Related]  

  • 11. Hereditary adrenocortical unresponsiveness to adrenocorticotropic hormone.
    Kelch RP; Kaplan SL; Biglieri EG; Daniels GH; Epstein CJ; Grumbach MM
    J Pediatr; 1972 Oct; 81(4):726-36. PubMed ID: 4342294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Day-night secretory rhythms of adrenocortical steroids in kidney disease patients with nycturia].
    Hohenegger M
    Endokrinologie; 1966 Dec; 50(5):260-6. PubMed ID: 5989928
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of metyrapone on aldosterone secretion in man.
    Tucci JR; Espiner EA; Jagger PI; Lauler DP
    Acta Endocrinol (Copenh); 1967 Nov; 56(3):376-84. PubMed ID: 4293345
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenocortical responses during tularemia in human subjects.
    Beisel WR; Bruton J; Anderson KD; Sawyer WD
    J Clin Endocrinol Metab; 1967 Jan; 27(1):61-9. PubMed ID: 4225306
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some findings on the androgen functions of the adrenal cortex in female obesity].
    Ferramosca B; Bacci G; Frizziero L; Masiello O
    Endocrinol Sci Cost; 1967 Nov; 29(5):323-43. PubMed ID: 4892898
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of an adrenal 11-beta, 17-alpha hydroxylase inhibitor in juvenile-onset diabetes mellitus.
    Narduzzi JV; Sabeh G; Weir TF; Cleary WJ; Danowski TS
    Clin Pharmacol Ther; 1967; 8(5):684-91. PubMed ID: 4293304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M; Luton JP; Mathieu de Fossey B; Bricaire H
    Presse Med (1893); 1968 May; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Repercussion of corticotherapy on the hypothalamo-pituitary-adrenal axis function].
    Bloch-Michel H; Gorins A; Thevenet M
    Presse Med (1893); 1970 Mar; 78(13):599-601. PubMed ID: 4314719
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in adrenocortisol function of patients with gonadal dysgenesis after treatment with estrogen.
    Sobrinho LG; Kase NG; Grunt JA
    J Clin Endocrinol Metab; 1971 Jul; 33(1):110-4. PubMed ID: 4934139
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of specific treatment on the adrenal cortex function in patients with syphilis].
    Shteĭn AA; Dubovyĭ MI; Shcherbakova AK
    Vestn Dermatol Venerol; 1968 Aug; 42(8):58-61. PubMed ID: 5741103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.